Adjuvante Endokrine Therapie: Risiko von Hitzewallungen und Schlafstörungen bei Frauen
European regulators have approved lasofoxifene, a selective estrogen receptor modulator (SERM)—a class of drugs that mimics estrogen in specific tissues while blocking it in others—as a first-line treatment for moderate-to-severe ... Read More